Your browser doesn't support javascript.
loading
Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer.
Song, Yurong; Kerr, Travis D; Sanders, Chelsea; Dai, Lisheng; Baxter, Shaneen S; Somerville, Brandon; Baugher, Ryan N; Mellott, Stephanie D; Young, Todd B; Lawhorn, Heidi E; Plona, Teri M; Xu, Bingfang; Wei, Lei; Hu, Qiang; Liu, Song; Hutson, Alan; Karim, Baktiar; Burkett, Sandra; Difilippantonio, Simone; Pinto, Ligia; Gebert, Johannes; Kloor, Matthias; Lipkin, Steven M; Sei, Shizuko; Shoemaker, Robert H.
Afiliación
  • Song Y; Frederick National Laboratory for Cancer Research, Vaccine, Immunity, and Cancer Directorate, Frederick, MD, United States.
  • Kerr TD; Frederick National Laboratory for Cancer Research, Vaccine, Immunity, and Cancer Directorate, Frederick, MD, United States.
  • Sanders C; Frederick National Laboratory for Cancer Research, Laboratory Animal Sciences Program, Frederick, MD, United States.
  • Dai L; Frederick National Laboratory for Cancer Research, Vaccine, Immunity, and Cancer Directorate, Frederick, MD, United States.
  • Baxter SS; Frederick National Laboratory for Cancer Research, Vaccine, Immunity, and Cancer Directorate, Frederick, MD, United States.
  • Somerville B; Frederick National Laboratory for Cancer Research, Vaccine, Immunity, and Cancer Directorate, Frederick, MD, United States.
  • Baugher RN; Frederick National Laboratory for Cancer Research, Clinical Laboratory Improvement Amendments (CLIA) Molecular Diagnostics Laboratory, Frederick, MD, United States.
  • Mellott SD; Frederick National Laboratory for Cancer Research, Clinical Laboratory Improvement Amendments (CLIA) Molecular Diagnostics Laboratory, Frederick, MD, United States.
  • Young TB; Frederick National Laboratory for Cancer Research, Clinical Laboratory Improvement Amendments (CLIA) Molecular Diagnostics Laboratory, Frederick, MD, United States.
  • Lawhorn HE; Frederick National Laboratory for Cancer Research, Clinical Laboratory Improvement Amendments (CLIA) Molecular Diagnostics Laboratory, Frederick, MD, United States.
  • Plona TM; Frederick National Laboratory for Cancer Research, Clinical Laboratory Improvement Amendments (CLIA) Molecular Diagnostics Laboratory, Frederick, MD, United States.
  • Xu B; Frederick National Laboratory for Cancer Research, Genomics Laboratory, Frederick, MD, United States.
  • Wei L; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.
  • Hu Q; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.
  • Liu S; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.
  • Hutson A; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.
  • Karim B; Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
  • Burkett S; Molecular Cytogenetics Core Facility, National Cancer Institute, Frederick, MD, United States.
  • Difilippantonio S; Frederick National Laboratory for Cancer Research, Laboratory Animal Sciences Program, Frederick, MD, United States.
  • Pinto L; Frederick National Laboratory for Cancer Research, Vaccine, Immunity, and Cancer Directorate, Frederick, MD, United States.
  • Gebert J; Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
  • Kloor M; Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
  • Lipkin SM; Department of Medicine, Weill Cornell Medical College, Cornell University, New York, NY, United States.
  • Sei S; Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States.
  • Shoemaker RH; Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States.
Front Oncol ; 13: 1223915, 2023.
Article en En | MEDLINE | ID: mdl-37746286
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos